These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
868 related articles for article (PubMed ID: 18780260)
1. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India. Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260 [TBL] [Abstract][Full Text] [Related]
2. Ocular manifestations of HIV infection. Jabs DA Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India. Shah SU; Kerkar SP; Pazare AR Br J Ophthalmol; 2009 Jan; 93(1):88-90. PubMed ID: 18952644 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000). Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD; Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751 [TBL] [Abstract][Full Text] [Related]
5. Seven years of HAART impact on ophthalmic management of HIV-infected patients. Kahraman G; Krepler K; Franz C; Ries E; Maar N; Wedrich A; Rieger A; Dejaco-Ruhswurm I Ocul Immunol Inflamm; 2005; 13(2-3):213-8. PubMed ID: 16019681 [TBL] [Abstract][Full Text] [Related]
6. [Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy]. Mesarić B; Lisić M; Kniewald T; Ugrinović N; Begovac J Lijec Vjesn; 2005; 127(5-6):123-8. PubMed ID: 16281473 [TBL] [Abstract][Full Text] [Related]
7. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis. Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432 [TBL] [Abstract][Full Text] [Related]
8. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy. Mihăilescu R; Arama V; Paraschiv S; Streinu-Cercel A; Oţelea D; Munteanu D; Iosipenco M; Chiotan C; Benea OE; Mărdărescu M; Rădulescu M; Hristea A; Ungurianu R; Aramă SS; Cercel AS; Călin R; Băicuş C Rom J Intern Med; 2008; 46(4):305-11. PubMed ID: 19480296 [TBL] [Abstract][Full Text] [Related]
9. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy. Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR Retina; 2000; 20(2):151-5. PubMed ID: 10783947 [TBL] [Abstract][Full Text] [Related]
10. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy. Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865 [TBL] [Abstract][Full Text] [Related]
11. Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era. Lai TY; Wong RL; Luk FO; Chow VW; Chan CK; Lam DS Clin Exp Ophthalmol; 2011 Mar; 39(2):99-104. PubMed ID: 20796263 [TBL] [Abstract][Full Text] [Related]
12. Ocular complications of human immunodeficiency virus infection in eastern china. Wang Z; Jia R; Ge S; He T; Zhang Y; Yang Y; Wang Y; Shi W; Ji Y; Ye F; Chen P; Lu J; Sun J; Xu X; Zhou Y; Gu P; Luo M; Lu H; Fan X Am J Ophthalmol; 2012 Feb; 153(2):363-369.e1. PubMed ID: 21982101 [TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and treatment of eye diseases associated with HIV infection and AIDS]. Geng S; Ye JJ; Liu LQ; Xu HY; Wang WW; Wang SR Zhonghua Yan Ke Za Zhi; 2009 Dec; 45(12):1093-8. PubMed ID: 20193432 [TBL] [Abstract][Full Text] [Related]
14. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL; Ophthalmology; 2006 Aug; 113(8):1441-5. PubMed ID: 16781775 [TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection. Kuo IC; Kempen JH; Dunn JP; Vogelsang G; Jabs DA Am J Ophthalmol; 2004 Sep; 138(3):338-46. PubMed ID: 15364214 [TBL] [Abstract][Full Text] [Related]
16. Proliferative vitreoretinopathy in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Kunavisarut P; Bijlsma WR; Pathanapitoon K; Patikulsila D; Choovuthayakorn J; Rothova A Am J Ophthalmol; 2010 Aug; 150(2):218-22. PubMed ID: 20525529 [TBL] [Abstract][Full Text] [Related]
17. Ophthalmic manifestation of aids in Armed Forces General Teaching Hospital, Addis Ababa. T/Giorgis A; Melka F; G/Mariam A Ethiop Med J; 2007 Oct; 45(4):327-34. PubMed ID: 18326342 [TBL] [Abstract][Full Text] [Related]
19. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL; Ophthalmology; 2006 Aug; 113(8):1432-40. PubMed ID: 16766032 [TBL] [Abstract][Full Text] [Related]
20. Effect of highly active antiretroviral therapy (HAART) on the natural history of ocular manifestations in HIV-infected children. Esposito S; Porta A; Bojanin J; Gualtieri L; Cesati L; Vismara E; Principi N Eye (Lond); 2006 May; 20(5):595-7. PubMed ID: 16410815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]